Quality and Regulatory Sourcebook eBook
Read the article:
Mitigating Human Error and Supporting Compliance with Smart Technology
Read the eBook:
BioPharm International’s Quality and Regulatory Sourcebook eBook
Mitigating Human Error and Supporting Compliance with Smart Technology
By Mike Wilson
Publication
Article
BioPharm InternationalBioPharm International Quality and Regulatory Sourcebook 2023
Volume 2023 eBook
Issue 1
Pages: 10–13
Technological advances hold promise for mitigating human error in the pharmaceutical industry, especially in quality assurance/quality control, by reducing the incidence of, and risk associated with, mistakes.
PHOTON_PHOTO - STOCK.ADOBE.COM
Facing new global challenges, pharmaceutical company leaders are looking to prioritize operational strategies to remain competitive in this rapidly evolving business environment. Recent events that range from the COVID-19 pandemic to new regulatory guidelines to economic inflation have required pharma manufacturers to find new ways to streamline workflows and minimize risks. Disruptions caused by the pandemic and related restrictions continue to impact supply chains and logistics worldwide. Additionally, many companies have shifted toward remote and hybrid working, and have increased their use of digital technologies to maintain business continuity and protect the health of employees.
These changes are accelerating the need for new innovations. One solution is the use of intelligent informatics in the pharmaceutical quality control (QC) laboratory to improve the quality and safety of drugs and reduce the risk of costly errors and recalls. However, while technology can simplify many workflows, it also comes with a learning curve and new burdens may be placed on its users. Pharma companies must determine the effectiveness of technological advancements and the potential challenges they may introduce in an environment like pharmaceutical quality assurance/quality control (QA/QC).
Read this article in BioPharm International’s March 2023 Quality and Regulatory Sourcebook eBook.
About the author
Mike Wilson, QA/QC Strategy, Waters Corporation
Article details
BioPharm International
eBook: Quality and Regulatory Sourcebook
March 2023
Pages: 10–13
Citation
When referring to this article, please cite it as Wilson, M. Mitigating Human Error and Supporting Compliance with Smart Technology. BioPharm International’s Quality and Regulatory Sourcebook eBook (March 2023).
Articles in this issue
Mitigating Human Error and Supporting Compliance with Smart Technology
Phase-appropriate Analytical Methodology
Evolution of Analytical Procedure Validation Concepts: Part II
Pharmacovigilance Automation
Evolution of Analytical Procedure Validation Concepts: Part I
Points to Consider for Knowledge Management Acceleration
Recent Videos
Related Content
Regeneron Treatment for Multiple Myeloma Gets Conditional Marketing Approval from EC
April 29th 2025Article
The indication is specific to patients who have received at least three prior therapies, including a proteasome inhibitor, immunomodulatory agent, and anti-CD38 monoclonal antibody, and have demonstrated disease progression on the last therapy.
MHRA Approves GSK Therapy Combinations for Multiple Myeloma
April 21st 2025Article
Belantamab mafodotin is approved in combination with bortezomib plus dexamethasone in patients who have had at least one prior therapy, and in combination with pomalidomide plus dexamethasone for those who have had a prior therapy including lenalidomide.
